Category: results

analysis, analytics, Aphria, business, Business Analysis, CANADA, canadian, cannabis, Cannin, Cannin Commentary, cbd, commentary, compliance, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, earnings, EBITDA, EU, europe, European, export, extraction, Federal, finance, financial, German, government, growing, holdings, import, industry, investing, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, product, Product Development, Q2, Quality, quarter, recreational, regulation, regulations, regulatory, report, reporting, results, retail, revenue, second, state, thc, Tilray

Is Tilray Stock a Buy Post Fiscal Q2 Results?

Is Tilray Stock a Buy Post Fiscal Q2 Results?

Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]

analysis, analytics, business, cannabis, certificate, COA, compliance, consumer, cultivation, dispensary, extraction, format, government, growing, industry, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, of, Pesticide, product, Quality, RC - Cannabis Analysis, read, recreational, regulation, regulations, regulatory, results, retail, safety, state, test, Testing, thc

The Importance of Understanding Cannabis Testing Results

The Importance of Understanding Cannabis Testing Results

Cannabis testing is important for both operators and consumers, but there are some differences in what is important to each group. Obviously, […]